just stick to the facts, page-15

I misunderstand nothing TV, you appear to know little about the commercial aspects of Bio's.

ADO should have received big upfront payments for even allowing Phillips/BBI to use ADO's products to improve their POC devices.

A long time ago I was invested in a small Bio which received a $20m upfront payment for allowing a big pharma to even get their hands on the small Bio's patented product. That was before they'd even tried to use it.

IMO ADO have already missed out. The more I read about Phillips the less I like them.

as for Sojourner et.al. they know nothing.


no more on ADO from me today.